Immune-enhancing diets for stressed patients with a special emphasis on arginine content: Analysis of the analysis

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 6, Issue 2, 2003, Pages 189-193

  Cynober, Luc ^a  

^a HÔTEL DIEU   (France)

Author keywords

Arginine; Enteral nutrition; Stress

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ARGININE; ASCORBIC ACID; GLUTAMINE; OMEGA 3 FATTY ACID; ORNITHINE OXOGLUTARATE; RETINOL; RNA; SELENIUM; VITAMIN; ZINC; IMMUNOLOGICAL ADJUVANT;

CLINICAL TRIAL; CONSENSUS; CRITICAL ILLNESS; DIET; DIET SUPPLEMENTATION; DRUG ADMINISTRATION ROUTE; ENTERIC FEEDING; HEALTH CARE COST; HEMODYNAMICS; HUMAN; IMMUNE SYSTEM; META ANALYSIS; MULTIPLE ORGAN FAILURE; POSTOPERATIVE PERIOD; REVIEW; STATISTICAL ANALYSIS; STRESS; SYSTEMATIC REVIEW; CELLULAR IMMUNITY; DIET THERAPY; DRUG EFFECT; IMMUNOLOGY; INTENSIVE CARE; METHODOLOGY; PATHOPHYSIOLOGY; POSTOPERATIVE CARE;

ADJUVANTS, IMMUNOLOGIC; ARGININE; CRITICAL ILLNESS; ENTERAL NUTRITION; HUMANS; IMMUNITY, CELLULAR; INTENSIVE CARE; POSTOPERATIVE CARE; STRESS;

EID: 0037491112     PISSN: 13631950     EISSN: None     Source Type: Journal    
DOI: 10.1097/00075197-200303000-00007     Document Type: Review

References (32)

1. Kudsk KA. Introduction. JPEN J Parenter Enteral Nutr 2001; 25 (Suppl):S1-S2.
2. Windmueller HG. Glutamine utilization by the small intestine. Adv Enzymol 1982; 53:202-237.
3. Bérard MP, Zazzo JF, Condat P, et al. Total parenteral nutrition enriched with arginine and glutamate generates glutamine and limits protein catabolism in surgical patients hospitalized in intensive care units. Crit Care Med 2000; 28:3637-3644.
4. Oltermann MH, Passas TR. Immunonutrition in a multidisciplinary ICU population: a review of the literature. JPEN J Parenter Enteral Nutr 2001; 25 (Suppl):S30-S35. This paper asks good questions.
5. Saffle JR, Wiebke G, Jennings K, et al. Randomized trial of immune-enhancing enteral nutrition in burn patients. J Trauma 1997; 42:793-802.
6. Martindale RG, Cresci GA. Use of immune-enhancing diets in burns. JPEN J Parenter Enteral Nutr 2001; 25 (Suppl):S24-S26. Another well balanced paper.
7. Moore FA. Effects of immune-enhancing diets on infectious morbidity and multiple organ failure. JPEN J Parenter Enteral Nutr 2001; 25 (Suppl):S36-S43. A sound analysis about the endpoints to be considered.
8. McClave SA. The effects of immune-enhancing diets on mortality, hospital length of stay, duration of mechanical ventilation and other parameters. JPEN J Parenter Enteral Nutr 2001; 25 (Suppl):S44-S50. This paper must be read, but it is a pity that wound healing as a major endpoint has been ignored.
9. Barbul A. The use of arginine in clinical practice. In: Cynober L, editor. Amino acid metabolism and therapy in health and nutritional disease. Boca Raton: CRC Press; 1995. pp. 361-372.
10. Heyland DK, Novak F. Immunonutrition in the critically ill patient: more harm than good? JPEN J Parenter Enteral Nutr 2001; 25 (Suppl):S51-S55.
11. Takala J, Ruokonen E, Webster NR, et al. Increased mortality associated with growth hormone treatment in critically ill adults. N Engl J Med 1999; 341:785-792.
12. Grimble RF. Interaction between nutrients, pro-inflammatory cytokines and inflammation. Clin Sci 1996; 91:121-130.
13. Jurkovich GJ. Outcome studies using immune-enhancing diets: blunt and penetrating torso trauma patients. JPEN J Parenter Enteral Nutr 2001; 25 (Suppl):S14-S18. Some freedom with statistics, but otherwise a sound analysis of the limitation of the literature.
14. Schloerb PR. Immune-enhancing diets: products, components and their rationales. JPEN J Parenter Enteral Nutr 2001; 25 (Suppl):3-7.
15. Sax HC. Effect of immune enhancing formulas in general surgery patients. JPEN J Parenter Enteral Nutr 2001; 25 (Suppl):S19-S23.
16. Alpers DH. Is glutamine a unique fuel for small intestinal cells? Curr Opin Gastroenterol 2000; 16:155-159.
17. Cynober L. Nitrogen pharmaconutrients from the laboratory to the bedside [In French], Nutr Clin Metabol 2001; 15:131-143.
18. Gottschlich MM, Jenkins M, Warden GD, et al. Differential effects of three enteral dietary regimens on selected outcome variables in burn patients. JPEN J Parenter Enteral Nutr 1990; 14:225-236.
19. Donati L, Ziegler F, Pongeli G, Signorini MS. Nutritional and clinical efficacy of ornithine α-ketoglutarate in severe burn patients. Clin Nutr 1999; 18:307-311.
20. De Bandt JP, Coudray-Lucas C, Lioret N, et al. A randomized controlled trial of the influence of the mode of enteral ornithine alpha-ketoglutarate administration in burn patients. J Nutr 1998; 128:563-569.
21. Coudray-Lucas C, Le Sever H, Cynober L, et al. Ornithine α-ketoglutarate improves wound healing in severe burn patients: a prospective randomized double-blind trial versus isonitrogenous controls. Crit Care Med 2000; 28:1772-1776.
22. Le Boucher J, Obled C, Farges MC, Cynober L. Ornithine alpha-ketoglutarate modulates tissue protein metabolism in burn-injured rats. Am J Physiol Endocrinol Metab 1997; 273:E557-E563.
23. Vaubourdolle M, Coudray-Lucas C, Jardel A, et al. Action of enteralty-administered ornithine α-ketoglutarate on protein breakdown in skeletal muscle and liver in the burned rat. JPEN J Parenter Enteral Nutr 1991; 15:517-520.
24. Roch-Arveiller M, Tissot M, Coudray-Lucas C, et al. Immunomodulatory effects of ornithine α-ketoglutarate in rats with burn injuries. Arch Surg 1996; 131:718-723.
25. Moinard C, Chauveau B, Walrand S, et al. Phagocyte functions in stressed rats: comparison of modulation by glutamine, arginine and ornithine 2-oxoglutarate. Clin Sci 1999; 97:59-65.
26. Moinard C, Caldefie F, Walrand S, et al. Involvement of glutamine, arginine, and polyamines in the action of ornithine α-ketoglutarate on macrophage functions in stressed rats. J Leukoc Biol 2000; 67:834-840.
27. Cynober L, Coudray-Lucas C. Ornithine alpha-ketoglutarate administration in surgical, trauma and cancer-bearing patients. In: Lafati R, Merell RC, editors. Nutritional support in cancer and transplant patients. Georgetown: Landes Bioscience; 2001. pp. 144-155. The most recent review on OKG in ICU patients.
28. Consensus recommendations from the US summit on immune-enhancing enteral therapy. JPEN J Parenter Enteral Nutr 2001; 25 (Suppl):S61-S62.
29. Heyland DK, Novak F, Drover JW, et al. Should immunonutrition become routine in critically ill patients? JAMA 2001; 286:22-29. A fascinating meta-analysis which led to numerous comments. The authors are probably right in underlining that large amounts of Arg may be deleterious in unstable critically ill patients; however, currently available data do not support this intuitive hypothesis.
30. Tepaske R, Velthuis HT, Oudemas-Van Straaten HM, et al. Effect of preoperative oral immune-enhancing nutritional supplement on patients at high risk of infection after cardiac surgery: a randomised placebo-controlled trial. Lancet 2001; 358:696-701. An interesting study, but uncertainties regarding the equivalence in nitrogen intake between groups and the fact that some patients received post-operative enteral nutrition obscure the conclusions.
31. Houdijk AP, Rijnsburger ER, Jansen J, et al. Randomised trial of glutamine-enriched enteral nutrition on infectious morbidity in patients with multiple trauma. Lancet 1998; 352:772-776.
32. Shi HP, Efron DT, Tantry US, Barbul A. Supplemental dietary arginine enhances wound healing in normal but not inducible nitric oxide synthase knockout mice. Surgery 2000; 128:374-378.